Trial Profile
Efficacy and tolerability of bendamustine in patients with methotrexate refractory recurrent primary CNS lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2014
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary)
- Indications CNS cancer; Lymphoma
- Focus Adverse reactions; Therapeutic Use
- 01 Oct 2014 New trial record